Renin: Measurements, Correlates, and Associations With Long-Term Adverse Kidney Outcomes
- 3 October 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 36 (1), 42-49
- https://doi.org/10.1093/ajh/hpac112
Abstract
The association of renin with adverse kidney outcomes is largely unknown, and renin measurement strategies vary. We aimed to measure the clinical correlates of different renin measurements and the association between renin and incident chronic kidney disease (CKD), end-stage kidney disease (ESKD), and mortality. We performed a prospective cohort analysis of 9,420 participants in the Atherosclerosis Risk in Communities study followed from 1996 to 1998 through 2019. We estimated longitudinal associations of renin measured using SomaScan modified nucleotide aptamer assay with incident CKD, ESKD, and death using Cox proportional hazards models. Using samples from a subsequent study visit, we compared SomaScan renin with plasma renin activity (PRA) and renin level from Olink, and estimated associations with covariates using univariate and multivariable regression. Higher SomaScan renin levels were associated with a higher risk of incident CKD (hazard ratio per two-fold higher [HR], 1.14; 95% confidence interval [CI], 1.09 to 1.20), ESKD (HR, 1.20; 95% CI, 1.03 to 1.41), and mortality (HR, 1.08; 95% CI, 1.04 to 1.13) in analyses adjusted for demographic, clinical, and socioeconomic covariates. SomaScan renin was moderately correlated with PRA (r = 0.61) and highly correlated with Olink renin (r = 0.94). SomaScan renin and PRA had similar clinical correlates except for divergent associations with age and beta-blocker use, both of which correlated positively with SomaScan renin but negatively with PRA. SomaScan aptamer-based renin level was associated with a higher risk of CKD, ESKD, and mortality. It was moderately correlated with PRA, sharing generally similar clinical covariate associations.Keywords
Funding Information
- National Institutes of Health
- Department of Health and Human Services (HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700005I, HHSN268201700004I, R01DK089174)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01HL134320)
- National Heart, Lung, and Blood Institute (T32HL007024, T32HL139426)
This publication has 40 references indexed in Scilit:
- Plasma renin activity and the aldosterone-to-renin ratio are associated with the development of chronic kidney diseaseJournal of Hypertension, 2012
- Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin CThe New England Journal of Medicine, 2012
- Association of plasma renin activity and aldosterone–renin ratio with prevalence of chronic kidney diseaseJournal of Hypertension, 2011
- Aptamer-Based Multiplexed Proteomic Technology for Biomarker DiscoveryPLOS ONE, 2010
- Plasma Renin Activity Predicts Blood Pressure Responses to -Blocker and Thiazide Diuretic as Monotherapy and Add-On Therapy for HypertensionAmerican Journal of Hypertension, 2010
- Activity Assays and Immunoassays for Plasma Renin and Prorenin: Information Provided and Precautions Necessary for Accurate MeasurementClinical Chemistry, 2009
- Plasma renin and risk of cardiovascular disease and mortality: the Framingham Heart StudyEuropean Heart Journal, 2007
- Association of the Renin-Sodium Profile with the Risk of Myocardial Infarction in Patients with HypertensionThe New England Journal of Medicine, 1991
- The renin response to diuretic therapyl A limitation of antihypertensive potential.Circulation Research, 1978
- Postural Augmentation of Plasma Renin Activity and Aldosterone Excretion in Normal People*JCI Insight, 1967